Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.97)
# 1,379
Out of 5,150 analysts
884
Total ratings
39.54%
Success rate
0.83%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio | Initiates: Buy | $13 | $4.73 | +174.84% | 1 | Feb 25, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $231 → $239 | $208.95 | +14.38% | 23 | Feb 24, 2026 | |
| FBIO Fortress Biotech | Reiterates: Buy | $17 | $3.10 | +448.39% | 5 | Feb 23, 2026 | |
| ARMP Armata Pharmaceuticals | Maintains: Buy | $9 → $15 | $11.61 | +29.20% | 16 | Feb 23, 2026 | |
| ANL Adlai Nortye | Upgrades: Buy | $16 | $8.38 | +90.93% | 5 | Feb 13, 2026 | |
| APRE Aprea Therapeutics | Maintains: Buy | $5 → $4 | $0.91 | +339.56% | 16 | Jan 29, 2026 | |
| CALC CalciMedica | Downgrades: Neutral | n/a | $0.62 | - | 13 | Jan 29, 2026 | |
| TPST Tempest Therapeutics | Upgrades: Buy | $11 | $2.34 | +370.09% | 20 | Jan 22, 2026 | |
| KURA Kura Oncology | Reiterates: Buy | $40 | $8.55 | +367.84% | 29 | Jan 13, 2026 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 → $310 | $265.00 | +16.98% | 35 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $62.27 | +118.40% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.46 | +387.80% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.58 | +416.00% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $97 | $26.45 | +266.73% | 25 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $4.64 | +50.86% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $60 | $25.50 | +135.29% | 27 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.50 | +1,503.21% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $4.73 | +26.85% | 19 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $28.18 | +66.78% | 6 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $6.30 | +312.70% | 18 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.95 | +361.54% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $0.70 | +2,042.86% | 33 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $4.26 | +111.27% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $31.18 | +66.77% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $29.63 | +92.37% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $32.14 | +217.36% | 35 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.19 | +2,000.84% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.91 | +449.83% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.96 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.63 | +145.40% | 23 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.31 | +248.03% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $29.54 | +42.18% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $31.43 | -4.55% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $9.03 | +10.74% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $28.88 | +45.43% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.15 | +1,117.39% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.23 | +225.20% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.34 | +4,173.50% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $3.11 | +92.93% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.81 | +825.27% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.40 | +11,566.67% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.04 | +1,534.62% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $8.30 | +285.54% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.17 | +5,241.25% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.39 | +1,194.96% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $5.69 | +321.79% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.42 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $5.51 | +462.61% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.63 | +1,805.37% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $16.22 | +128.11% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.81 | +507.73% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $21.23 | -67.03% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.91 | +2,646.95% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.96 | +10,332.97% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.54 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.17 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $29.19 | +13.05% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $5.81 | +1,242.51% | 1 | Mar 24, 2017 |
Q32 Bio
Feb 25, 2026
Initiates: Buy
Price Target: $13
Current: $4.73
Upside: +174.84%
Ligand Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $231 → $239
Current: $208.95
Upside: +14.38%
Fortress Biotech
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $3.10
Upside: +448.39%
Armata Pharmaceuticals
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $11.61
Upside: +29.20%
Adlai Nortye
Feb 13, 2026
Upgrades: Buy
Price Target: $16
Current: $8.38
Upside: +90.93%
Aprea Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $5 → $4
Current: $0.91
Upside: +339.56%
CalciMedica
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.62
Upside: -
Tempest Therapeutics
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $2.34
Upside: +370.09%
Kura Oncology
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $8.55
Upside: +367.84%
Krystal Biotech
Jan 9, 2026
Reiterates: Buy
Price Target: $240 → $310
Current: $265.00
Upside: +16.98%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $62.27
Upside: +118.40%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $2.46
Upside: +387.80%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.58
Upside: +416.00%
Dec 11, 2025
Maintains: Buy
Price Target: $104 → $97
Current: $26.45
Upside: +266.73%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $4.64
Upside: +50.86%
Dec 3, 2025
Maintains: Buy
Price Target: $24 → $60
Current: $25.50
Upside: +135.29%
Dec 2, 2025
Reiterates: Buy
Price Target: $8
Current: $0.50
Upside: +1,503.21%
Dec 1, 2025
Upgrades: Buy
Price Target: $6
Current: $4.73
Upside: +26.85%
Nov 28, 2025
Reiterates: Buy
Price Target: $47
Current: $28.18
Upside: +66.78%
Nov 26, 2025
Reiterates: Buy
Price Target: $26
Current: $6.30
Upside: +312.70%
Nov 24, 2025
Maintains: Buy
Price Target: $9
Current: $1.95
Upside: +361.54%
Nov 13, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $0.70
Upside: +2,042.86%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $4.26
Upside: +111.27%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $31.18
Upside: +66.77%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $29.63
Upside: +92.37%
Sep 29, 2025
Reiterates: Buy
Price Target: $102
Current: $32.14
Upside: +217.36%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.19
Upside: +2,000.84%
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $2.91
Upside: +449.83%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.96
Upside: -
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $4.31
Upside: +248.03%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $29.54
Upside: +42.18%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $31.43
Upside: -4.55%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $9.03
Upside: +10.74%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $28.88
Upside: +45.43%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.15
Upside: +1,117.39%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.34
Upside: +4,173.50%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $3.11
Upside: +92.93%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $2.81
Upside: +825.27%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.40
Upside: +11,566.67%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.04
Upside: +1,534.62%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $8.30
Upside: +285.54%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.17
Upside: +5,241.25%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.39
Upside: +1,194.96%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $5.69
Upside: +321.79%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.42
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $5.51
Upside: +462.61%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.63
Upside: +1,805.37%
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $16.22
Upside: +128.11%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.81
Upside: +507.73%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $21.23
Upside: -67.03%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.91
Upside: +2,646.95%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.96
Upside: +10,332.97%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $29.19
Upside: +13.05%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $5.81
Upside: +1,242.51%